Lombard Medical Inc (EVAR)

0.05
0.00 (0.00)
OTC : Health Care
Prev Close 0.05
Open 0.05
Day Low/High 0.05 / 0.05
52 Wk Low/High 0.02 / 0.75
Volume 1.43K
Avg Volume 79.70K
Exchange OTC
Shares Outstanding 27.95M
Market Cap 6.15M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Lombard Medical's New Delivery System For Aorfix™ Endovascular Aortic Aneurysm Repair System Launched In Japan

Lombard Medical's New Delivery System For Aorfix™ Endovascular Aortic Aneurysm Repair System Launched In Japan

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm (AAA) endovascular repair products, today announced the full commercial launch in Japan of its new...

Lombard Medical Appoints Jonathan Hornsby As Vice President, Sales & Marketing

Lombard Medical Appoints Jonathan Hornsby As Vice President, Sales & Marketing

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced the appointment of Jonathan Hornsby as Vice President, Sales & Marketing,...

Lombard Medical Announces Completion Of Restructuring And Implementation Of Strategic Plan To Achieve Profitability

Lombard Medical Announces Completion Of Restructuring And Implementation Of Strategic Plan To Achieve Profitability

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new strategy to...

Lombard Medical Announces First Patient Enrolled And Treated In The ALTITUDE Registry For The Altura® Stent Graft System

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that it has enrolled and treated the first patient in its global registry to...

Lombard Medical's Endovascular Product Portfolio Presented At Scientific Sessions Of The 39th Annual Charing Cross International Symposium

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that its portfolio of endovascular stent graft systems, Altura® and...

Lombard Medical Appoints New CEO

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer,...

Lombard Medical Reports 2016 Fourth Quarter, Full Year Financial Results

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair of abdominal aortic aneurysms, today reported financial results for the fourth quarter and year ended December 31, 2016.

Lombard Medical's CEO Steps Down

Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Simon Hubbert has stepped down from his position as CEO on April 18 after...

Lombard Medical And MicroPort Scientific Corporation Finalize Strategic Partnership Agreements

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio...

Lombard Medical Announces Successful Completion Of First 15 Cases In Japan For IntelliFlex™ LP Delivery System For The Aorfix™ Endovascular Stent Graft

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that physicians in Japan have successfully treated the...

Lombard Medical Announces Regulatory Approval In Japan For IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

Lombard Medical Announces Regulatory Approval In Japan For IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced approval from the Japanese Ministry of Health, Labour and...

Lombard Medical And MicroPort Scientific Corporation Announce Strategic Partnership And Investment Agreement

Lombard Medical And MicroPort Scientific Corporation Announce Strategic Partnership And Investment Agreement

Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio...

Multi-Centre Early Experience And Data Presented On Lombard Medical's Altura® Endovascular Stent Graft At The 43rd Annual VEITHsymposium™

Multi-Centre Early Experience And Data Presented On Lombard Medical's Altura® Endovascular Stent Graft At The 43rd Annual VEITHsymposium™

UK - Manchester Group of Hospitals presented early experience and 100% technical success in 24 patients treated with Altura

Lombard Medical Receives NASDAQ Notice Of Bid Price Deficiency

Lombard Medical Receives NASDAQ Notice Of Bid Price Deficiency

No Immediate Effect on Listing - EVAR Has 180 Days to Regain Compliance

Lombard Medical Announces Scientific Presentations On Aorfix™ And Altura® Endovascular Stent Grafts At The 43nd Annual VEITHsymposium™

Lombard Medical Announces Scientific Presentations On Aorfix™ And Altura® Endovascular Stent Grafts At The 43nd Annual VEITHsymposium™

Debut of Data on New IntelliFlex™ Delivery System and Clinical Experience with Altura

Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results And Provides Update On Strategic Initiatives

Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results And Provides Update On Strategic Initiatives

Commercial Restructuring Shifts Focus Exclusively to Europe, Japan and Key International Markets; Announces Process to Explore Strategic Alternatives  to Maximize Shareholder Value

Lombard Medical Expands European Launch Of Its New Altura® Endograft System

Lombard Medical Expands European Launch Of Its New Altura® Endograft System

Multiple Patients Successfully Treated with Altura in the Netherlands and Spain

Lombard Medical Announces First Commercial Use Of Its New IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

Lombard Medical Announces First Commercial Use Of Its New IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

IntelliFlex LP's Lower Catheter Profile Expands Aorfix Treatment to More Patients

Lombard Medical Announces CE Mark Approval For IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

Lombard Medical Announces CE Mark Approval For IntelliFlex™ LP Delivery System For The Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft

New, Innovative Design Enhances Control and Precision During Placement with the Potential to Reduce Vessel Trauma

Lombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results In AAA Patients With Challenging Anatomy

Lombard Medical Reports Positive Five-Year Aorfix™ Endovascular Stent Graft Clinical Results In AAA Patients With Challenging Anatomy

Aorfix Remains the Only Global On-Label Solution for Tortuous AAA Anatomy

Lombard Medical Provides Update On Controlled Launch Of The New Altura® Endovascular Stent Graft In Europe

Lombard Medical Provides Update On Controlled Launch Of The New Altura® Endovascular Stent Graft In Europe

Controlled Launch Expanded to 37 Centers in the UK and Germany